Imaging Beta-Amyloid Peptides Aggregation
AssigneeHong Kong Baptist University
InventorsYinhui LI, Di XU, See-Lok HO, Chung-Yan POON, Hei-Nga CHAN, Hung Wing LI, Ricky M. S. WONG
Life of this patent
Estimating the term…
Loading patent…
AssigneeHong Kong Baptist University
InventorsYinhui LI, Di XU, See-Lok HO, Chung-Yan POON, Hei-Nga CHAN, Hung Wing LI, Ricky M. S. WONG
Estimating the term…
The present invention is in the field of pharmaceuticals and chemical industries. In particular, one aspect of the present invention relates to methods for labeling, imaging and detecting the beta-amyloid (Aβ) peptides, oligomers, and fibrils in vitro and in vivo via magnetic resonance and florescence imaging by using modified carbazole-based fluorophores. A further aspect of the present invention relates to a method of reducing and preventing aggregation of beta-amyloid peptides for Alzheimer's disease (AD) as well as of treating and/or preventing Alzheimer's disease by using the modified carbazole-based fluorophore. The modified carbazole-based fluorophore according to an embodiment of the present invention is prepared by conjugating a carbazole-based fluorophore with magnetic nanoparticles to form a conjugate which is permeable to blood brain barrier of a subject being introduced therewith.
A method for imaging and detection of beta-amyloid (Aβ) peptides aggregation via magnetic resonance imaging (MRI) based on modified carbazole-based fluorophores comprising a formula S series:
A method for imaging and detection of beta-amyloid (Aβ) peptides aggregation via fluorescence imaging based on modified carbazole-based fluorophores comprising a formula S series:
Dependencies are inferred from the claim text.